OPS-2

N/A

Report date: 2024/06/03 15:15:40
NME

Base Information

Drug NameOPS-2
Drug Alias NameOPS-2OPS2
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTriple Negative Breast NeoplasmsLymphoma, Non-HodgkinLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncopeptides Ab
China Registration ClassN/A

Develop Information

Active CompaniesOncopeptides Ab
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsLymphoma, Non-HodgkinLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A